Hematology Reports
Published by Multidisciplinary Digital Publishing Institute (MDPI)
ISSN : 2038-8322 eISSN : 2038-8330
Abbreviation : Hematol. Rep.
Aims & Scope
Hematology Reports is an Open Access, online-only, peer-reviewed journal that considers mainly original articles, case reports and reviews on all aspects of prevention, diagnosis and management of disorders of the blood, as well as related molecular and cell biology, genetics, pathophysiology, epidemiology and controlled trials.
Manuscripts on laboratory and clinical aspects of blood-related conditions are welcome, as well as research on the treatment of blood diseases.
Occasional issues and supplements publish an in-depth clinical and biological analysis of particular types of blood diseases.
The journal also reviews important recent developments in the biology and treatment of malignant diseases, and highlights promising new directions.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 1.2 |
2024 | 1.10 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.374 |
Quartile
Year | Value |
---|---|
2024 | Q3 |
h-index
Year | Value |
---|---|
2024 | 19 |
Journal Rank
Year | Value |
---|---|
2024 | 14476 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 173 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy
Citation: 59
Authors: Oluwatoyin Olatundun
-
Extranodal diffuse large B-cell lymphomas: A retrospective case series and review of the literature
Citation: 22
Authors: Stergios, Ioannis, Amalia, Eleni, Esmeralda, Alexandra, Nicholas, Anna, George
-
Expression of some ATP-binding cassette transporters in acute myeloid leukemia
Citation: 22
Authors: Antonella Maria, Flavia, Sabrina, Roberta, Immacolata, Sara Pasquina, Faustino, Michele, Angela
-
Splenomegaly impacts prognosis in essential thrombocythemia and polycythemia vera: A single center study
Citation: 20
Authors: Vincenzo, Marco, Simona, Angelo Davide, Paolo, Florinda, Alessandro, Antonio, Sergio
-
Impact of voxelotor (GBT440) on unconjugated bilirubin and jaundice in sickle cell disease
Citation: 18
Authors: Paul, Irene, Kathleen M., Laurie, Timothy, Marzena, Margaret, Josh
-
GBT440 reverses sickling of sickled red blood cells under hypoxic conditions in vitro
Citation: 17
Authors: Kobina, Donna
-
The role of red cell distribution width in the differential diagnosis of iron deficiency anemia and non-transfusion dependent thalassemia patients
Citation: 16
Authors: Pokpong, Adisak, Thanawat, Chatree, Ekarat, Lalita
-
Cardiotoxicity of tyrosine kinase inhibitors in chronic myelogenous leukemia therapy
Citation: 16
Authors: Zhenshu, Shundong, Ting, Delong
-
Human hemoglobin G-Makassar variant masquerading as sickle cell anemia
Citation: 14
Authors: Ahmad Sabry, Roszymah, Veena, Subramanian, Jameela